Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,564 (5,079, 8,068)","49.4% (35.5%, 63.2%)","72.9% (56.4%, 87.3%)","17.6% (11.7%, 27.2%)","95.2% (91.9%, 96.8%)","12.3 (8.9, 15.8)","18.2 (14.1, 21.8)","4.4 (2.9, 6.8)","23.8 (23.0, 24.2)",,,,,
"p=(None, None), q=(None, None), c=0.500, f=1.00)","6,833 (5,220, 8,359)","60.5% (39.6%, 79.4%)","68.5% (50.8%, 84.2%)","15.8% (10.4%, 25.1%)","96.1% (92.8%, 98.0%)","15.1 (9.9, 19.8)","17.1 (12.7, 21.0)","4.0 (2.6, 6.3)","24.0 (23.2, 24.5)","4.1% (0.7%, 8.7%)","22.6% (7.0%, 48.9%)","-6.2% (-11.2%, -2.7%)","-10.2% (-18.6%, -3.9%)","1.0% (-1.6%, 3.4%)"
"p=(None, None), q=(None, None), c=0.750, f=1.00)","6,993 (5,326, 8,689)","61.3% (39.6%, 79.5%)","67.3% (48.5%, 83.4%)","15.2% (9.9%, 24.0%)","96.3% (93.3%, 97.9%)","15.3 (9.9, 19.9)","16.8 (12.1, 20.9)","3.8 (2.5, 6.0)","24.1 (23.3, 24.5)","6.6% (2.2%, 12.4%)","24.2% (6.9%, 49.4%)","-7.9% (-14.5%, -3.2%)","-13.5% (-23.7%, -6.7%)","1.1% (-1.4%, 3.8%)"
"p=(None, None), q=(None, None), c=1.000, f=1.00)","7,175 (5,408, 9,010)","61.8% (39.6%, 82.5%)","66.1% (46.8%, 82.8%)","14.7% (9.2%, 23.9%)","96.2% (92.8%, 98.0%)","15.4 (9.9, 20.6)","16.5 (11.7, 20.7)","3.7 (2.3, 6.0)","24.1 (23.2, 24.5)","9.3% (3.1%, 19.0%)","25.4% (7.2%, 50.6%)","-9.6% (-17.6%, -3.6%)","-16.8% (-28.2%, -8.0%)","1.1% (-1.5%, 3.6%)"
